Inadequate and poor-quality outcome reporting in transplant clinical trials is a known barrier that impedes the ability of researchers to evaluate, replicate, synthesize, and build upon study findings and impacts evidence-based decision-making by patients, clinicians, and policy-makers. Using cardiovascular disease as an example, we will discuss and examine a set of evidence-informed and consensus-based standards focused on outcome reporting in clinical trials that can be applied across all solid organ transplantation.
“This Masterclass has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.”Attendance to the live Masterclass and the completion of the post-event survey are mandatory to receive the certificate and CME credits.
“Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.
“Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.”
Presentation: Defining cardiovascular outcomes in transplantation and the implications for trials design, John Gill, Canada
Live Q&A with John Gill, Canada
Presentation: Transparency in outcomes reporting clinical trials in transplantation, Jonathan C. Craig, Australia
Presentation: Patient engagement and transparency in outcomes reporting in transplantation, Allison Tong, Australia
Masterclass closing remarks